‌

US Patent 11976084 Spiropyrrolidine derived antiviral agents

Patent 11976084 was granted and assigned to Enanta Pharmaceuticals on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

0

Current Assignee

Enanta Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yat Sun Or0

Xuri Gao0

Xuechao Xing0

Yong He0

Hui Cao0

Joseph D. Panarese0

Ruichao Shen0

Jun Ma0

...

Date of Patent

May 7, 2024

0

Patent Application Number

175318440

Date Filed

November 22, 2021

0

Patent Citations

US Patent 9328147 Recombinant baculovirus vector and uses thereof

0

US Patent 9347044 Reprogramming T cells and hematopoietic cells

0

US Patent 9428739 Norovirus and Sapovirus antigens

0

US Patent 9447382 Generation of induced pluripotent stem cells from small volumes of peripheral blood

0

US Patent 9474759 Broad-spectrum antivirals against 3C or 3C-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses

0

US Patent 9512443 Recombinant expression of multiprotein complexes using polygenes

0

US Patent 9587235 Histidyl-tRNA synthetase-Fc conjugates

0

US Patent 9591858 None

0

...

Patent Primary Examiner

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11976084 Spiropyrrolidine derived antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.